Framingham Risk Calculator - 10-Year CVD Risk Score

A Framingham risk calculator turns a small set of cardiovascular inputs into a 10-year risk percentage using the D'Agostino 2008 general CVD model from the Framingham Heart Study. It is built for adults aged 30 to 74 with no prior cardiovascular event who want a structured look at age, sex, cholesterol, blood pressure, smoking, and diabetes in one place. The page shows the 10-year risk, a heart-age estimate, and a low, intermediate, or high risk band so the result is easier to discuss with a clinician.

• • Routine primary-care check: Bring an age, sex, blood pressure, and lipid reading into one place before an annual physical so the conversation can focus on what to change.
• • Lifestyle change tracking: Recompute the score after quitting smoking, lowering total cholesterol, or improving blood pressure to see how much the 10-year number moves.
• • Family history review: Compare a person's risk to the same age and sex with optimal modifiable factors so the inherited portion of risk is easier to see.

The Framingham Heart Study began in 1948 in Framingham, Massachusetts, and produced some of the most cited risk equations in preventive cardiology. The 2008 general CVD model published by D'Agostino and colleagues was designed for primary care, so it is meant to be used before any heart attack, stroke, or peripheral artery disease has occurred. The aim is a transparent number that summarizes the interaction of age, sex, blood pressure, cholesterol, smoking, and diabetes in a single percentage.

Body-mass index is not a direct input in the D'Agostino 2008 general CVD model, so the BMI Calculator sits next to this calculator to give context when weight status is part of the conversation.

The D'Agostino 2008 model fits separate Cox proportional-hazards equations for men and women using data from 8,491 Framingham study participants. Each input is multiplied by a published coefficient, summed, and compared to a model-specific baseline survival to produce a 10-year risk probability.

• Age: Years (30 to 74). Log-transformed in the equation.
• Total cholesterol: mg/dL from a lipid panel. Log-transformed.
• HDL cholesterol: mg/dL. Higher HDL lowers predicted risk.
• Systolic BP: mmHg at rest. Uses one coefficient for treated and another for untreated.
• Smoker and diabetes: Binary clinical status flags added to the linear predictor.
• Baseline survival S0(10) and mean coefficient: 0.88936 and 23.9802 for men, 0.95012 and 26.1931 for women, used to anchor and center the equation.

The model's published baseline survival of 0.88936 for men and 0.95012 for women acts as the anchor: 1 minus that baseline is the average 10-year CVD rate in the original Framingham cohort, and each person's risk either rises above or falls below that average depending on their inputs.

According to Framingham Heart Study, the male and female 10-year general CVD risk models combine age, total and HDL cholesterol, treated and untreated systolic blood pressure, smoking, and diabetes in a sex-specific Cox proportional-hazards equation

According to D'Agostino et al. 2008, a sex-specific multivariable risk algorithm derived from 8,491 Framingham study participants predicted 10-year general cardiovascular disease risk with a C-statistic of 0.763 in men and 0.793 in women

A single clinic reading is not the only way to populate the systolic field, and the Blood Pressure Calculator is a useful reference for averaging home readings before they go into the linear predictor.

Four ideas explain what the number means and how the inputs combine. They are worth keeping separate so the result is read as a probability, not a verdict.

Total cholesterol and HDL cholesterol have opposite effects in the model. Total cholesterol is a risk factor that raises the linear predictor, while HDL is protective with a negative coefficient.

Low-density lipoprotein is not an input in the published D'Agostino 2008 equation, but the LDL Calculator can fill that gap when a clinician wants the same lipid panel reported in a different way.

The fastest workflow is to use a recent lipid panel and a resting blood pressure, then enter the inputs in the same order the form presents them.

1. 1 Enter age and sex: Type the age in whole years between 30 and 74 and choose the sex option that matches the lipid panel and blood pressure record.
2. 2 Enter the lipid panel: Use the most recent total and HDL cholesterol values in mg/dL. If your lab reports in mmol/L, the conversion is 1 mg/dL equals 0.02586 mmol/L for cholesterol.
3. 3 Enter blood pressure and treatment: Use a resting systolic reading, ideally the average of two or three home or office measurements on the same day. Indicate whether the person is on antihypertensive treatment at the time of the reading.
4. 4 Mark smoking and diabetes status: Select current smoker if the person smoked cigarettes within the last year. Select diabetes if there is an active clinical diagnosis or treatment.
5. 5 Read the result and the optimal comparison: Look at the 10-year risk, the heart age, the risk band, and the optimal comparison. The difference between the current risk and the optimal comparison is the modifiable share.
6. 6 Repeat after lifestyle or treatment changes: Recompute the score after stopping smoking, lowering blood pressure, or improving the lipid panel to see how the 10-year number moves.

A 55-year-old man with total cholesterol 200, HDL 50, systolic BP 130, not on treatment, non-smoker, no diabetes has a 10-year risk of 11.1% in the intermediate band. The optimal comparison at the same age and sex is 5.4%, so about half of the 11.1% is modifiable.

If the lipid panel reports cholesterol in mmol/L, the Cholesterol Units Calculator converts the value to mg/dL so it can be entered into the form without losing precision.

The 10-year risk is most useful when it supports a specific decision. The benefits below are the practical situations where the calculator adds value beyond a single number.

• • Single 10-year summary: Combines age, sex, cholesterol, blood pressure, smoking, and diabetes into one percentage that is easier to track than six separate readings.
• • Heart age translation: Translates the linear predictor into an age a non-clinician can compare against, which often makes the result easier to act on.
• • Modifiable share visibility: Shows the gap between the current 10-year risk and the optimal comparison, so it is clearer how much of the risk is reachable through lifestyle and treatment.
• • Risk band for triage: Sorts results into low, intermediate, and high bands so a primary-care visit can be planned around the band.
• • Sex-specific calculation: Uses the male and female coefficient sets separately, which avoids the common error of using a unisex model.
• • Repeatable reassessment: Can be recomputed as blood pressure, lipids, and smoking status change, so the score is a moving target.

The benefit list matters most when one or more inputs actually change. A score that is repeated after stopping smoking, after starting a statin, or after losing weight becomes a feedback loop. A score computed once and never revisited is just a number.

The ratio between total and HDL cholesterol is a useful companion number to the 10-year risk, and the Cholesterol Ratio Calculator reports it on the same lipid panel without needing a second draw.

Inputs do not carry the same weight. The factors below explain which inputs move the result the most, what the calculator can and cannot see, and the most important limitations to keep in mind when reading the 10-year risk.

• • The published model is validated for ages 30 to 74 with no prior cardiovascular event. Results outside that range should be treated as a model extrapolation, not a published risk.
• • The cohort is largely of European ancestry, so the model can overestimate or underestimate risk in some other groups, and ethnicity-specific recalibration is a clinical decision.

Inputs are intentionally kept simple. A single home blood pressure reading, a self-reported smoking history, and a fasting lipid panel are enough to get a useful number, and the page reports when the inputs are outside the published range or when the result is in the high band. The Framingham risk calculator should be used alongside a clinician's assessment, not in place of it.

According to AHA/ACC 2013 Cardiovascular Risk Guideline, adults aged 40 to 79 without known cardiovascular disease should have their 10-year risk estimated as a first step in shared decision-making about lipid, blood pressure, and lifestyle therapy

The D'Agostino 2008 model does not include body-fat distribution, so the Waist-to-Hip Ratio Calculator provides a quick read on central adiposity that can add context to the calculated 10-year risk.